Alivus Life Sciences Ltd
BSE:
NSE:ALIVUS
ALIVUS Share Price
BSE:
NSE:ALIVUS
Pharmaceuticals
Small Cap
₹-
0 (0%)
Market Cap
₹13,517.83Cr
PE Ratio
31.92
Alivus Life Sciences Ltd Performance
▲
▲
▲
▲
Alivus Life Sciences Ltd Fundamentals
Alivus Life Sciences Ltd Delivery and Volume
About Alivus Life Sciences Ltd
Glenmark Life Sciences Limited was incorporated as Zorg Laboratories Private Limited', on June 23, 2011 at Pune and was granted the Certificate of Incorporation by the Registrar of Companies, Maharashtra at Pune. Subsequently, the Company was acquired by Glenmark Pharmaceuticals Limited through a Sh
| Name | Designation |
|---|---|
| Yasir Yusufali Rawjee | Managing Director & CEO |
| Vinod Naik | Executive Director |
| Manju Agarwal | Independent Non Exe. Director |
| Taruvai Laxminarayanan Easwar | Independent Non Exe. Director |
| HIREN KARSANBHAI PATEL | Chairman (Non-Executive) |
| KAUSHIKBHAI NANDUBHAI PATEL | Independent Director |
| VIJAYKUMAR RATILAL SHAH | Independent Director |
| Savan Godialwala | Independent Director |
| Rudalf Corriea | Company Sec. & Compli. Officer |
News and Events...
Top Gainers Today
View All
Top Losers Today
View All
Alivus Life Sciences Ltd FAQs
How do I Buy Alivus Life Sciences Ltd Shares?
By opening a demat account and having your KYC papers confirmed online, you may simply purchase Alivus Life Sciences Ltd shares in BlinkX.
What is the Share Price of Alivus Life Sciences Ltd?
The share price of any stock is volatile and changes during the day due to a variety of variables. Alivus Life Sciences Ltd's share price is ₹1149.9 as of 2025-01-21.
What is the PE ratio of Alivus Life Sciences Ltd?
Alivus Life Sciences Ltd's P/E ratio is 31.92 times as of 2025-01-21.
What is the PB ratio of Alivus Life Sciences Ltd?
Alivus Life Sciences Ltd's most recent financial reports indicate a price-to-book ratio of 5.33, showing the company's stock market valuation in relation to the value of its real assets.
What is the Market Cap of Alivus Life Sciences Ltd?
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Alivus Life Sciences Ltd's market capitalization is ₹13517.83 Cr as on 2025-01-21.
What is the ROE of Alivus Life Sciences Ltd?
The current financial records of Alivus Life Sciences Ltd show a 21.07% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
What is the Total Asset of Alivus Life Sciences Ltd?
According to Alivus Life Sciences Ltd's most recent financial filings, the company has a total asset value of ₹1920.55, which includes current and non-current assets such as inventory, cash, properties, and equipment.
What is the 52-week high and Low of Alivus Life Sciences Ltd?
The 52-week high/low price of a Alivus Life Sciences Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Alivus Life Sciences Ltd's 52-week high and low as of 2025-01-21 are ₹1213.7 and ₹1095, respectively.
